Eli Lilly Opens New Gateway Labs in San Diego

September 26, 2025
Eli Lilly has opened its newest Lilly Gateway Labs site in San Diego, expanding its network of innovation hubs for early-stage biotech companies.

Eli Lilly and Company has officially opened its latest Lilly Gateway Labs (LGL) site in San Diego, California, announced in a press release. This new facility expands Lilly's network of shared innovation hubs designed to support early-stage biotechnology companies by providing lab space and opportunities for collaboration with Lilly scientists.

Located on the One Alexandria Square Megacampus in Torrey Pines, the San Diego site features 82,514 square feet of flexible laboratory and office space. It can accommodate up to 15 life sciences companies and more than 250 employees. The facility offers startups access to wet lab facilities, scientific engagement, and strategic guidance to aid in drug discovery and development.

Lilly Gateway Labs San Diego is the fourth U.S. site, joining two locations in South San Francisco and one in Boston. The model is also expanding globally, with a newly opened site in Beijing. Since the inception of the first Gateway Labs site in 2019, companies based at these labs have raised over $2 billion in capital, supporting the development of more than 50 therapeutics and platforms.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

09/26
Elsevier Appoints Brent Gordon as President of Healthcare Education
09/26
Deep EigenMatics Secures US Patent for AI-Driven Protein Design
09/26
BetterAge Secures $5.5M in NIH Grants for Aging Platform
09/26
Axtria Wins Minsky Award at Cypher 2025
09/26
Generate:Biomedicines to Present Phase 1 Results for AI-Engineered Asthma Treatment

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like